67 engineering-computation "https:" "https:" "https:" "https:" "https:" "https:" uni jobs at Nature Careers in United States
Sort by
Refine Your Search
-
Title: Associate or Senior Editor, Nature Communications (Computational Social Science) Location: New York, Jersey City, Philadelphia, Madrid, Shanghai, Pune or Delhi Closing date: January 30th
-
, excelling in engineering and technology. The Zhejiang University International Business School (ZIBS): A premier hub for global business innovation and leadership. iZJU is led by a distinguished team of
-
service missions; specifically prioritizing the alignment of scientists and research infrastructure with departmental and institutional strategies and program priorities, including those essential
-
). Thanks to your collaborative and influencing skills, you partner with internal stakeholders (e.g. Informatics Vendor Management Team, other Procurement Teams) to align on needs, identify opportunities
-
will be withdrawn. Review of Applications Begins On: 01/16/2026 Website: https://www.canr.msu.edu/rdsp/ Reproductive and Developmental Sciences Program (RDSP): Michigan State University boasts a
-
Large Employer by Forbes in 2021. Driven by an intensely collaborative and entrepreneurial character, UAB is one of the leading economic engines of the State, with a nearly $4 billion budget and a
-
Title: Associate or Senior Editor, Nature Communications (Digital health and computational biology) Location: New York, Jersey City, Philadelphia or Shanghai Closing date: February 6th, 2026. About
-
engineering who are eager to develop transformative technologies and biologics to treat cancer. About the Center The CCTCI is a newly established, interdisciplinary center dedicated to accelerating
-
Job Description Title: Associate or Senior Editor, Nature Computational Science Organization: Nature Portfolio Location: Shanghai, Beijing, New York or New Jersey - Hybrid Working Model Closing date
-
indications. BMTCT also provides a cellular therapy program, which includes the use of viral specific T-cells (VSTs), chimeric antigen receptor (CAR) engineered T-cells and gene therapy products. As a clinical